Works matching DE "ZIPRASIDONE"
Results: 214
Prevalence of contraindicated combinations amid behavioral and mental health medications filled in a pediatric population.
- Published in:
- BMC Primary Care, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12875-024-02528-9
- By:
- Publication type:
- Article
Involvement of Cholinergic System in Hyperactivity in Dopamine-Deficient Mice.
- Published in:
- Neuropsychopharmacology, 2015, v. 40, n. 5, p. 1141, doi. 10.1038/npp.2014.295
- By:
- Publication type:
- Article
Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2011, v. 36, n. 3, p. 616, doi. 10.1038/npp.2010.193
- By:
- Publication type:
- Article
Lithium-induced acute intermittent dystonia in a patient with schizoaffective disorder.
- Published in:
- European Psychiatry, 2016, v. 33, p. S671, doi. 10.1016/j.eurpsy.2016.01.1993
- By:
- Publication type:
- Article
Comparative effects of ziprasidone and quetiapine on sleep physiology measures in patients with major depressive disorder.
- Published in:
- European Psychiatry, 2016, v. 33, p. S743, doi. 10.1016/j.eurpsy.2016.01.2219
- By:
- Publication type:
- Article
Ziprasidone Associated Sexual Hyperarousal: a Case Report.
- Published in:
- European Psychiatry, 2015, v. 30, p. 930, doi. 10.1016/S0924-9338(15)30728-8
- By:
- Publication type:
- Article
Pharmacogenetics of Adverse Events in Schizophrenia Treatment: Comparison Study of Ziprasidone, Olanzapine and Perazine.
- Published in:
- European Psychiatry, 2015, v. 30, p. 1680, doi. 10.1016/S0924-9338(15)31287-6
- By:
- Publication type:
- Article
New Treatment Strategies of Dissociative Symptoms in Bipolar Disorder: Three Case Report with Literature Review.
- Published in:
- European Psychiatry, 2015, v. 30, p. 549, doi. 10.1016/S0924-9338(15)30433-8
- By:
- Publication type:
- Article
Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: A pragmatic, randomized trial
- Published in:
- European Psychiatry, 2013, v. 28, n. 3, p. 174, doi. 10.1016/j.eurpsy.2011.10.003
- By:
- Publication type:
- Article
2839 – Ziprasidone augmentation of lamotrigine in treatment depersonalization in bipolar disorder.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
2283 – Safety and tolerability of aripiprazole once-monthly initiated in adults with schizophrenia stabilized on atypical oral antipsychotics other than aripiprazole.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
1403 – Hyperprolactinemia and antipsychotic use in psychiatric patients.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
P-1081 - The effects of metoprolol and diltiazem in prolonged QTc interval caused by ziprasidone injection in rats
- Published in:
- 2012
- By:
- Publication type:
- Abstract
P-1098 - Ziprasidone as adjunctive therapy in patients with schizoaffective or bipolar disorder treated with clozapine
- Published in:
- 2012
- By:
- Publication type:
- Abstract
P03-126 - Cardiovascular side effects, QT interval in patients treated with some selected antypsychotics. preliminary results
- Published in:
- 2011
- By:
- Publication type:
- Abstract
P02-452 - Dystonia and acute psychotic episode complicated by neuroleptic malignant syndrome in an adolescent with CYP2D6 deficiency
- Published in:
- 2011
- By:
- Publication type:
- Abstract
P03-368 Use of antipsychotics in patients with schizophrenia and cognitive impairment: A naturalistic survey across four European countries
- Published in:
- 2011
- By:
- Publication type:
- Abstract
P03-341 - Meta-analysis of the efficacy of asenapine for acute schizophrenia: comparisons with placebo and other atypical antipsychotics
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Use of ziprasidone in patients with schizophrenia in four European countries
- Published in:
- European Psychiatry, 2011, v. 26, n. 1, p. 29, doi. 10.1016/S0924-9338(11)71711-4
- By:
- Publication type:
- Article
Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia.
- Published in:
- Indian Journal of Psychiatry, 2012, v. 54, n. 3, p. 248, doi. 10.4103/0019-5545.102425
- By:
- Publication type:
- Article
Neuroprotective effect of ziprasidone: Preliminary results compared to haloperidol.
- Published in:
- Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2014, v. 31, n. 2, p. 71, doi. 10.5835/jecm.omu.31.02.002
- By:
- Publication type:
- Article
Acne caused by ziprasidone in a young patient with bipolar disorder: A case report.
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.948977
- By:
- Publication type:
- Article
Ziprasidone-induced sub acute cutaneous lupus erythematosus.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Crystal structure of ziprasidone hydrochloride monohydrate, C21H22Cl2N4OS(H2O).
- Published in:
- Powder Diffraction, 2015, v. 30, n. 3, p. 192, doi. 10.1017/S0885715615000305
- By:
- Publication type:
- Article
Patient choice as a driver of medication-switching in non-adherent individuals with bipolar disorder.
- Published in:
- Patient Preference & Adherence, 2014, v. 8, p. 487, doi. 10.2147/PPA.S56790
- By:
- Publication type:
- Article
Natural gums as sustained release carriers: development of gastroretentive drug delivery system of ziprasidone HCl.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2012, v. 20, p. 1, doi. 10.1186/2008-2231-20-58
- By:
- Publication type:
- Article
Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review.
- Published in:
- Expert Review of Clinical Pharmacology, 2011, v. 4, n. 2, p. 163, doi. 10.1586/ecp.10.139
- By:
- Publication type:
- Article
Open prospective study of ziprasidone in patients with schizophrenia with depressive symptoms: A multicenter study.
- Published in:
- Psychiatry & Clinical Neurosciences, 2015, v. 69, n. 1, p. 43, doi. 10.1111/pcn.12212
- By:
- Publication type:
- Article
Anti-leucine-rich glioma-inactivated 1 encephalitis with manic symptoms as the initial manifestation.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study.
- Published in:
- Journal of Psychopharmacology, 2012, v. 26, n. 9, p. 1201, doi. 10.1177/0269881111430748
- By:
- Publication type:
- Article
Human Hemoglobin and Antipsychotics Clozapine, Ziprasidone and Sertindole: Friends or Foes?
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 10, p. 8921, doi. 10.3390/ijms24108921
- By:
- Publication type:
- Article
Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 4, p. 551, doi. 10.3390/ijms17040551
- By:
- Publication type:
- Article
Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming.
- Published in:
- Journal of Molecular Medicine, 2022, v. 100, n. 4, p. 599, doi. 10.1007/s00109-022-02181-8
- By:
- Publication type:
- Article
Cognitive Effects of Reducing First-Generation Antipsychotic Dose Compared to Switching to Ziprasidone in Long-Stay Patients with Schizophrenia.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 7, p. 2112, doi. 10.3390/jcm13072112
- By:
- Publication type:
- Article
SCHIZOFRENIE V ADOLESCENCI A JEJÍ LÉČBA.
- Published in:
- Ceská a Slovenská Psychiatrie, 2022, v. 118, n. 4, p. 163
- By:
- Publication type:
- Article
Adverse effects of antipsychotics on sleep in patients with schizophrenia. Systematic review and meta-analysis.
- Published in:
- Frontiers in Psychiatry, 2023, p. 1, doi. 10.3389/fpsyt.2023.1189768
- By:
- Publication type:
- Article
Physiologically‐based pharmacokinetics of ziprasidone in pregnant women.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 5, p. 914, doi. 10.1111/bcp.13872
- By:
- Publication type:
- Article
Optimal sampling of antipsychotic medicines: a pharmacometric approach for clinical practice.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 78, n. 4, p. 800, doi. 10.1111/bcp.12410
- By:
- Publication type:
- Article
Ziprasidone-induced hypersensitivity syndrome confirmed by reintroduction.
- Published in:
- International Journal of Dermatology, 2014, v. 53, n. 4, p. e267, doi. 10.1111/ijd.12246
- By:
- Publication type:
- Article
REGARDING "A RISPERIDONE-INDUCED PROLACTINOMA RESOLVED WHEN A WOMAN WITH SCHIZOAFFECTIVE DISORDER SWITCHED TO ZIPRASIDONE: A CASE REPORT".
- Published in:
- 2013
- By:
- Publication type:
- Letter
A Risperidone-Induced Prolactinoma Resolved when a Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report.
- Published in:
- Innovations in Clinical Neuroscience, 2012, v. 9, n. 9, p. 21
- By:
- Publication type:
- Article
Evidence for clinicians: Atypical antipsychotics for disruptive behaviour disorders in children and youths.
- Published in:
- Paediatrics & Child Health (1205-7088), 2019, v. 24, n. 2, p. 125, doi. 10.1093/pch/pxy156
- By:
- Publication type:
- Article
High-Performance Liquid Chromatographic Assay for Ziprasidone in Plasma Samples: Application to Pharmacokinetic Studies in Rats.
- Published in:
- Journal of Chromatographic Science, 2012, v. 50, n. 10, p. 902, doi. 10.1093/chromsci/bms088
- By:
- Publication type:
- Article
Long-Term Antipsychotic Effectiveness in First Episode of Psychosis: A 3-Year Follow-Up Randomized Clinical Trial Comparing Aripiprazole, Quetiapine, and Ziprasidone.
- Published in:
- International Journal of Neuropsychopharmacology, 2018, v. 21, n. 12, p. 1090, doi. 10.1093/ijnp/pyy082
- By:
- Publication type:
- Article
Clozapine is gold standard, but questions remain.
- Published in:
- International Journal of Neuropsychopharmacology, 2012, v. 15, n. 9, p. 1201, doi. 10.1017/S1461145712000284
- By:
- Publication type:
- Article
Ziprasidone Induces Rabbit Atrium Arrhythmogenesis via Modification of Oxidative Stress and Sodium/Calcium Homeostasis.
- Published in:
- Biomedicines, 2022, v. 10, n. 5, p. 976, doi. 10.3390/biomedicines10050976
- By:
- Publication type:
- Article
A paired case-control comparison of ziprasidone on visual sustained attention and visual selective attention in patients with paranoid schizophrenia.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2015, v. 19, n. 16, p. 2952
- By:
- Publication type:
- Article
A twenty-four-week, open-label study on Ziprasidone's efficacy and influence on glucolipid metabolism in patients with schizophrenia and metabolic disorder.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2013, v. 17, n. 16, p. 2136
- By:
- Publication type:
- Article
Long-term safety of ziprasidone in schizophrenic patients: an open trial.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2012, v. 16, n. 15, p. 2113
- By:
- Publication type:
- Article
Effects of the modified electric convulsive treatment (MECT) on cell factors of schizophrenia.
- Published in:
- Experimental & Therapeutic Medicine, 2017, v. 13, n. 3, p. 873, doi. 10.3892/etm.2017.4075
- By:
- Publication type:
- Article